Ragupathy Viswanath, Zhao Jiangqin, Wang Xue, Wood Owen, Lee Sherwin, Burda Sherri, Nyambi Phillipe, Hewlett Indira
Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
AIDS Res Ther. 2009 Nov 25;6:27. doi: 10.1186/1742-6405-6-27.
With the advent of entry inhibitors, monitoring of viral tropism in the clinical setting is important. Conventional methods are cell-based and lengthy, therefore V3 sequence based prediction algorithms are becoming increasingly attractive as monitoring tools. Here we report a comparative analysis of viral tropism of strains circulating in Cameroon where diverse and emerging variant strains are prevalent.
Viruses were isolated from 17 HIV positive individuals from three cities in Cameroon. Ghost cell lines expressing either CCR5 or CXCR4 with CD4 or CD4 alone (NIH AIDS Reagent Program) were used to determine co-receptor usage. HIV replication was determined by measuring p24 antigen levels. Plasma viral load (VL) was determined using the Versant bDNA assay. Nucleotide sequencing was performed on the V3 region and sequences were edited, aligned and translated into amino acids as described in the algorithm. Bio-informatics tools based on the 11/25 and charge rule were used to predict co-receptor usage.
The majority of patient isolates in our study were CRF02_AG or CRF02_AG containing recombinants. Tropism of these complex viruses based on the cell culture assay was determined to be R5 in 15/17 (88.2%) patients. However, two patient isolates were dual tropic R5X4 and had drug-specific mutations. Of these two patients, one was on antiretroviral treatment with a VL of 20,899 copies/ml and the other was drug-naïve with 141,198 copies/ml. Genotype based prediction was overall in good agreement with phenotype for R5 viruses, where 93% (14/15) of results were comparable, dual tropic viruses being reported as X4 viruses by prediction.
Our results indicate that most HIV strains in Cameroon were R5 tropic and some harbored drug-resistant mutations. V3 sequence based prediction compared well with cell based assays for R5 strains and may be useful even in settings where highly diverse strains are prevalent.
随着进入抑制剂的出现,在临床环境中监测病毒嗜性很重要。传统方法基于细胞且耗时较长,因此基于V3序列的预测算法作为监测工具正变得越来越有吸引力。在此,我们报告了对喀麦隆流行的多种新兴变异毒株的病毒嗜性的比较分析。
从喀麦隆三个城市的17名HIV阳性个体中分离病毒。使用表达CCR5或CXCR4以及单独表达CD4或仅表达CD4的幽灵细胞系(美国国立卫生研究院艾滋病试剂计划)来确定共受体使用情况。通过测量p24抗原水平来确定HIV复制情况。使用Versant bDNA测定法测定血浆病毒载量(VL)。对V3区域进行核苷酸测序,并按照算法所述对序列进行编辑、比对并翻译成氨基酸。使用基于11/25和电荷规则的生物信息学工具来预测共受体使用情况。
我们研究中的大多数患者分离株为CRF02_AG或含有CRF02_AG的重组体。基于细胞培养试验,这些复杂病毒在15/17(88.2%)的患者中被确定为R5嗜性。然而,有两个患者分离株为双嗜性R5X4,且具有药物特异性突变。在这两名患者中,一名正在接受抗逆转录病毒治疗,病毒载量为20,899拷贝/毫升,另一名未接受过治疗,病毒载量为141,198拷贝/毫升。对于R5病毒,基于基因型的预测总体上与表型结果高度一致,其中93%(14/15)的结果具有可比性,双嗜性病毒通过预测被报告为X4病毒。
我们的结果表明,喀麦隆的大多数HIV毒株为R5嗜性,一些毒株携带耐药突变。对于R5毒株,基于V3序列的预测与基于细胞的试验结果比较吻合,即使在毒株高度多样化的环境中也可能有用。